Realizing the clinical potential of ischemic preconditioning and postconditioning.
about
Nitric oxide and peroxynitrite in health and diseaseCardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic MedicationsPhysiology and pharmacology of myocardial preconditioning and postconditioning.Physiology and pharmacology of myocardial preconditioning.Seizure preconditioning and epileptic tolerance: models and mechanismsLeptin, the obesity-associated hormone, exhibits direct cardioprotective effectsRedox signalling and cardioprotection: translatability and mechanismRemote ischaemic postconditioning protects the heart during acute myocardial infarction in pigsEndocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningEthanol for cardiac ischemia: the role of protein kinase c.Aging and cardioprotection.CRYAB and HSPB2 deficiency alters cardiac metabolism and paradoxically confers protection against myocardial ischemia in aging mice.Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.Remote limb ischemic postconditioning protects against neonatal hypoxic-ischemic brain injury in rat pups by the opioid receptor/Akt pathway.Post-ischemic brain damage: effect of ischemic preconditioning and postconditioning and identification of potential candidates for stroke therapy.The emerging role of the endocannabinoid system in cardiovascular disease.Molecular mechanisms of liver preconditioningMyocardial postconditioning: next step to cardioprotection.Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injuryOverview of Experimental and Clinical Findings regarding the Neuroprotective Effects of Cerebral Ischemic Postconditioning.Treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates ischemic acute kidney injury.TLR5 Activation through NF-κB Is a Neuroprotective Mechanism of Postconditioning after Cerebral Ischemia in Mice.The NCX3 isoform of the Na+/Ca2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning.The evolving story of "conditioning" to protect against acute myocardial ischaemia-reperfusion injuryDiabetes and heart failure in patients with coronary disease: separating markers from mediators.ASIC1a contributes to neuroprotection elicited by ischemic preconditioning and postconditioningNitroglycerin-induced preconditioning: interaction with nitrate tolerance.Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.Effective neuroprotection by ischemic postconditioning is associated with a decreased expression of RGMa and inflammation mediators in ischemic rats.Cardioprotection by ischemic postconditioning is abolished in depressed rats: role of Akt and signal transducer and activator of transcription-3.Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury.Neuroprotection induced in vitro by ischemic preconditioning and postconditioning: modulation of apoptosis and PI3K-Akt pathways.Identifying needs and opportunities for advancing translational research in cardiovascular diseaseFoxO4 promotes myocardial ischemia-reperfusion injury: the role of oxidative stress-induced apoptosis
P2860
Q24645400-FD710A68-3DE5-42E7-BF25-F0DDECBF638AQ26824616-C083BE11-DBB5-4D4B-A0BC-9B4FCEF34F19Q30448088-19D737A4-5E7A-4C27-998D-7DD0B4E6F8A4Q30450862-57DF3603-47C3-4EDD-BC0B-ADC40920C05DQ34617266-62AAFF1D-0CC6-47F4-8E72-62B15E4E2C7AQ35119948-EC0E71BB-BEDD-44C5-AB26-3D00385C5498Q35286322-D19BDE90-C903-4F29-885D-B4C0AA08833AQ35954778-D597B402-4CD4-4479-BEB9-4842D09EED21Q36416372-02014B9D-AA3A-4B25-A3F3-4E776EE1C6A7Q36694026-C1C779D8-DA91-4487-926A-B64060DBA01DQ36918511-E26FFAD3-7E80-48D5-BF3B-934606393361Q36933115-E0909827-B104-4684-BE54-B0CC31F1D0F7Q36977542-44EA5E5A-CEA1-4D59-BCD5-F7088692B6FAQ36988971-79AEC122-22A0-4259-ABF1-3E4A8260B56BQ37352186-07BCAD4C-9015-4E0A-BB3E-2A7D7B10DCBEQ37439386-E9966C9D-2B22-4DB2-B75E-6D541D8F5CA0Q37823543-DE133B6D-58B3-49CA-A545-A8D3E27A09D8Q37942779-8BDD74E0-5089-415E-AED1-C2B774A05D07Q38177382-2652CA6E-BDA9-42B8-BA17-F55020FE454AQ38571725-ACB466A7-B618-4AC6-84C3-6CC1102969B9Q38687573-3804B7C7-ECEC-4A8F-9592-29E636CB5519Q39285622-A38A9AF8-D978-4F0E-AF0C-7D9C0E5C51DEQ41128427-ED7134E9-436E-4AA8-9631-036054B245F6Q42093080-F6CE2CCD-6B09-4DD9-810A-1D2137BD0CB0Q42409835-3EFCC075-5395-490A-BB1B-80BD1B9DB89FQ42480014-0B8C8E62-684A-4AB9-BFFF-D7F6688205C4Q42708243-35022F20-3BB6-4071-99A8-949681936C6DQ43222948-2D6DFDBE-4AA8-4042-BAE8-F6B0B4A7CD9FQ46687759-757E384D-3CAD-4155-AC39-F766B1D1F106Q48173233-C035FBAD-6BD0-4F9A-883B-181EAE6BDD5DQ49046559-A4C0F426-65B6-44FE-8E88-9C1947836F65Q50275842-419AC804-F342-4950-9E91-B68166973AE7Q54642083-49D074D5-0575-4053-9181-C3913E11C4E4Q56986575-5224A42B-7E64-45AF-89C9-468D44796EE9Q57493375-1AB13165-3D3D-403C-AD11-0CB852133E1D
P2860
Realizing the clinical potential of ischemic preconditioning and postconditioning.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@ast
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@en
type
label
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@ast
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@en
prefLabel
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@ast
Realizing the clinical potential of ischemic preconditioning and postconditioning.
@en
P2860
P356
P1476
Realizing the clinical potential of ischemic preconditioning and postconditioning
@en
P2860
P304
P356
10.1038/NCPCARDIO0346
P577
2005-11-01T00:00:00Z